Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1111/FEBS.16025 | ||||
| Año | 2021 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Human apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (hA3G), a member of the APOBEC family, was described as an anti-HIV-1 restriction factor, deaminating reverse transcripts of the HIV-1 genome. Several types of cancer cells that express high levels of A3G, such as diffuse large B-cell lymphoma cells and glioblastomas, show enhanced cell survival after ionizing radiation and chemotherapy treatments. Previously, we showed that hA3G promotes (DNA) double-strand breaks repair in cultured cells and rescues transgenic mice from a lethal dose of ionizing radiation. Here, we show that A3G rescues cells from the detrimental effects of DNA damage induced by ultraviolet irradiation and by combined bromodeoxyuridine and ultraviolet treatments. The combined treatments stimulate the synthesis of cellular proteins, which are exclusively associated with A3G expression. These proteins participate mainly in nucleotide excision repair and homologous recombination DNA repair pathways. Our results implicate A3G inhibition as a potential strategy for increasing tumor cell sensitivity to genotoxic treatments.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Botvinnik, Alexander | Hombre |
Hebrew Univ Hadassah Med Sch - Israel
Hebrew University-Hadassah Medical School - Israel Hebrew University of Jerusalem - Israel |
| 2 | Shivam, Pushkar | - |
Hebrew Univ Hadassah Med Sch - Israel
Hebrew University-Hadassah Medical School - Israel Hebrew University of Jerusalem - Israel |
| 3 | Smith, Yoav | Hombre |
Hebrew Univ Jerusalem - Israel
Hebrew University of Jerusalem - Israel |
| 4 | Sharma, Gunjan | Mujer |
Hebrew Univ Hadassah Med Sch - Israel
Hebrew University-Hadassah Medical School - Israel Hebrew University of Jerusalem - Israel |
| 5 | Olshevsky, Udy | - |
Hebrew Univ Hadassah Med Sch - Israel
Hebrew University-Hadassah Medical School - Israel Hebrew University of Jerusalem - Israel |
| 6 | Moshel, Ofra | Mujer |
Hebrew Univ Hadassah Med Sch - Israel
Faculty of Medicine - Israel Hebrew University of Jerusalem - Israel |
| 7 | Manevitch, Zakhariya | - |
Hebrew Univ Jerusalem - Israel
Hebrew University of Jerusalem - Israel |
| 8 | Climent, Nuria | Mujer |
Univ Barcelona - España
Universitat de Barcelona, Facultad de Medicina y Ciencias de la Salud - España |
| 9 | Oliva, H. | Hombre |
Veterquimica SA - Chile
Veterquímica S.A. - Chile |
| 10 | Britan-Rosich, Elena | Mujer |
Hebrew Univ Hadassah Med Sch - Israel
Hebrew University-Hadassah Medical School - Israel Hebrew University of Jerusalem - Israel |
| 11 | Kotler, Moshe | Hombre |
Hebrew Univ Hadassah Med Sch - Israel
Hebrew University-Hadassah Medical School - Israel Hebrew University of Jerusalem - Israel |
| Fuente |
|---|
| Canadian Institutes of Health Research |
| Israel Science Foundation (ISF) |
| Canadian Institutes of Health Research (CIHR) |
| Israel Science Foundation |
| International Development Research Centre |
| International Development Research Centre (IDRC) |
| Israel Cancer Foundation |
| Agradecimiento |
|---|
| We thank Dr R. S. Harris for his generous gift of SupT11A3G and Sup T11EV cells and Dr Michael Berger and Dr Sheera Adar for valuable discussion and critical reading of the manuscript. This research (grant No. 2665/16 MK) was carried out with the aid of a grant from the Canadian Institutes of Health Research (CIHR), the International Development Research Centre (IDRC), the Israel Science Foundation (ISF) and the Israel Cancer Foundation (20200084 MK). |
| We thank Dr R. S. Harris for his generous gift of SupT11 and Sup T11 cells and Dr Michael Berger and Dr Sheera Adar for valuable discussion and critical reading of the manuscript. This research (grant No. 2665/16 MK) was carried out with the aid of a grant from the Canadian Institutes of Health Research (CIHR), the International Development Research Centre (IDRC), the Israel Science Foundation (ISF) and the Israel Cancer Foundation (20200084 MK). A3G EV |